76 related articles for article (PubMed ID: 3554801)
1. [Effect of dithranol therapy on membrane, basement membrane and nuclear markers in psoriasis lesions].
Wollina U; Schlesier F; Schaarschmidt H; Knopf B; Hipler C; Henkel U; Roth H; Bartá U
Z Hautkr; 1987 Feb; 62(4):313-8. PubMed ID: 3554801
[TBL] [Abstract][Full Text] [Related]
2. [PUVA irradiation decreases the binding of membrane and basement membrane markers to human epidermis in vitro].
Wollina U; Schaarschmidt H; Schlesier F; Hipler C; Knopf B
Z Hautkr; 1987 Aug; 62(15):1151-4, 1157-8. PubMed ID: 3314211
[TBL] [Abstract][Full Text] [Related]
3. [A new Cologne therapy scheme--addition of tar to cignoline-salicylic acid-white vaseline therapy in psoriasis vulgaris].
Steigleder GK; Schulze HJ
Z Hautkr; 1984 Feb; 59(3):188, 191-2. PubMed ID: 6719977
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
5. [Experiences with high-dosage short-term dithranol therapy of psoriasis].
Göring HD; Voss M
Hautarzt; 1984 Mar; 35(3):148-51. PubMed ID: 6715170
[TBL] [Abstract][Full Text] [Related]
6. [Experiences in half-side treatment with tar additive to cignolin-salicylic-acid-white-vaseline therapy of psoriasis vulgaris].
Schulze HJ; Steigleder GK
Z Hautkr; 1984 May; 59(10):654-6. PubMed ID: 6741204
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy.
Wollina U; Schmidt WD; Koch A; Scheibe A; Erfurth F; Fassler D
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1409-13. PubMed ID: 19508501
[TBL] [Abstract][Full Text] [Related]
8. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
Mustakallio KK; Brandt H
Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
[TBL] [Abstract][Full Text] [Related]
9. [The effect of a tar admixture to dithranol-salicylic-acid-white-petrolatum therapy on the cytokinetics of psoriasis].
Schulze HJ; Steigleder GK; Pullmann H; Bloedhorn H
Z Hautkr; 1984 Mar; 59(5):288-90, 295-7. PubMed ID: 6719979
[TBL] [Abstract][Full Text] [Related]
10. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
[TBL] [Abstract][Full Text] [Related]
11. [Influence of dithranol therapy on clinical status and serum calcitonin concentrations in patients with common psoriasis].
Bendkowski W; Hadas E; Swietochowska E; Wielkoszyński T; Ostrowska Z; Szapska B
Pol Merkur Lekarski; 2002 Dec; 13(78):481-3. PubMed ID: 12666446
[TBL] [Abstract][Full Text] [Related]
12. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
13. PUVA irradiation restores altered binding patterns of lectins in psoriatic epidermis.
Danno K; Yoneda K; Horio T
Arch Dermatol; 1986 Jul; 122(7):772-8. PubMed ID: 2425750
[TBL] [Abstract][Full Text] [Related]
14. [Modified dithranol minute therapy of psoriasis vulgaris].
Chlebarov S; Rauh M
Z Hautkr; 1988 Aug; 63(8):658-62. PubMed ID: 3188606
[TBL] [Abstract][Full Text] [Related]
15. ["Minute therapy" of psoriasis with dithranol and its modifications. A critical evaluation based on 315 patients].
Runne U; Kunze J
Hautarzt; 1985 Jan; 36(1):40-6. PubMed ID: 3972578
[TBL] [Abstract][Full Text] [Related]
16. Positive direct immunofluorescence and autoantibody profiles in psoriasis patients.
Janjumratsang P; Phainupong D; Chanjanakijskul S; Roongphibulsopit P
J Dermatol; 2008 Aug; 35(8):508-13. PubMed ID: 18789071
[TBL] [Abstract][Full Text] [Related]
17. [Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)].
Ernst TM
Z Hautkr; 1981 Sep; 56(18):1197-206. PubMed ID: 7293304
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis.
Saraswat A; Agarwal R; Katare OP; Kaur I; Kumar B
J Dermatolog Treat; 2007; 18(1):40-5. PubMed ID: 17365266
[TBL] [Abstract][Full Text] [Related]
19. "Ditrawash"--a novel remover of dithranol (anthralin) for short contact therapy of psoriasis.
Mustakallio KK
Acta Derm Venereol Suppl (Stockh); 1989; 146():201-2. PubMed ID: 2609870
[TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test.
Barnadas MA; Gilaberte M; Pujol R; Agustí M; Gelpí C; Alomar A
Int J Dermatol; 2006 Sep; 45(9):1089-92. PubMed ID: 16961518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
